IMMX vs TT · $640.7M cap vs P/E 36, rev $11.32B
Immix Biopharma Inc (IMMX) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
IMMX does not have a complete income-statement cache yet.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
IMMX currently screens at market cap $640.7M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the IMMX and TT stock pages for the full models.
Not investment advice.